Surrogate Markers and Clinical Pharmacology
作者： Wayne A. Colburn
DOI: 10.1002/J.1552-4604.1995.TB04086.X
关键词:
摘要:
sci-hub.se 参考文章(6)
Richard Mamelok, How controversial are surrogate endpoints Nature Biotechnology. ,vol. 12, pp. 134- 135 ,(1994) , 10.1038/NBT0294-134
Dennis D. Spencer, Richard J. Robbins, Frederick Naftolin, Kenneth L. Marek, Timothy Vollmer, Csaba Leranth, Robert H Roth, Lawrence H. Price, Albert Gjedde, Benjamin S. Bunney, Kimberlee J. Sass, John D. Elsworth, E. Leon Kier, Robert Makuch, Paul B. Hoffer, D. Eugene Redmond, Unilateral Transplantation of Human Fetal Mesencephalic Tissue into the Caudate Nucleus of Patients with Parkinson's Disease The New England Journal of Medicine. ,vol. 327, pp. 1541- 1548 ,(1992) , 10.1056/NEJM199211263272201
J Cohen, Clinical trial monitoring: hit or miss? Science. ,vol. 264, pp. 1534- 1537 ,(1994) , 10.1126/SCIENCE.8202707
Jean W. Lee, James D. Hulse, Wayne A. Colburn, Surrogate biochemical markers: precise measurement for strategic drug and biologics development. The Journal of Clinical Pharmacology. ,vol. 35, pp. 464- 470 ,(1995) , 10.1002/J.1552-4604.1995.TB04089.X
Aram V. Chobanian, The 1988 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure Archives of Internal Medicine. ,vol. 148, pp. 1023- 1038 ,(1988) , 10.1001/ARCHINTE.1988.00380050029006
D. Von-Hagel, S. M. Dailey, W. J. Rogers, R. E. Little, J. Mahmarian, A. E. Epstein, S. Silber, C. Thomas, M. Cox, G. Morris, A. E. Walton, C. M. Pratt, J. G. Arciniegas, A. R. Baker, S. E. Papapietro, W. A H MacLean, T. Eaton, G. N. Kay, V. J. Plumb, Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction The New England Journal of Medicine. ,vol. 321, pp. 406- 412 ,(1989)